UPDATE: Isis Pharmaceuticals Earns $10M Milestone Payment from Biogen Idec
June 17, 2014 at 07:02 AM EDT
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today it has earned a $10 million milestone payment from Biogen Idec associated ...